Gilat (GILT) Rule 144 Notice — 5,934 Shares From 2022 Option

Rhea-AI Filing Summary

Form 144 summary for GILT: The filer notifies a proposed sale of 5,934 ordinary shares on or about 08/26/2025 through Oppenheimer & Co. on Nasdaq. These shares were acquired on 05/15/2022 under an employee stock option plan and are to be paid for in cash upon exercise. The filing lists 57,017,032 shares outstanding and an aggregate market value for the proposed sale of $55,126.86. The notice also discloses sales during the prior three months: 8,760 shares sold on 08/20/2025 for $79,278.00 and 7,160 shares sold on 08/21/2025 for $66,302.57. Several contact and issuer fields in the filing are blank or unspecified in the provided content.

Positive

• Transparent disclosure of a planned insider sale and two recent insider sales, including exact share counts and gross proceeds
• Source of shares disclosed as an employee stock option plan (acquired 05/15/2022), clarifying the nature of the holdings

Negative

• Insider selling activity in the past week totaling 15,920 shares for approximately $145,580 could be viewed negatively by some investors
• Missing issuer and filer contact details in the provided content limit full transparency about the filer and issuer relationship

Insights

Securities Analyst

TL;DR: Insider plans a small scheduled sale from 2022 option grant; recent nearby sales indicate ongoing disposition of shares.

The filing documents a planned sale of 5,934 ordinary shares executed through a broker on Nasdaq, acquired under an employee stock option plan on 05/15/2022 with cash upon exercise. The filer also reported two recent sales totaling 15,920 shares generating approximately $145,580 in gross proceeds on 08/20/2025 and 08/21/2025. As a percentage of the reported outstanding shares (57,017,032), these transactions are immaterial to share count but represent notable insider liquidity. The disclosure is routine for Rule 144 notices and provides transparency on insider selling activity.

Corporate Governance Expert

TL;DR: Form 144 is a compliant disclosure of insider selling; no governance red flags shown in provided text.

The notice contains required representations about non‑public material information and indicates the seller affirms no undisclosed material adverse information. The acquisition source is the issuer via an employee stock option plan, which is a common compensation mechanism. The filing lacks contextual issuer relationship details and some contact fields are blank in the provided content, limiting assessment of intent or any linked trading plans. Overall the filing appears procedurally correct based on the information supplied.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	5934	55126.86	57017032	08/26/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	05/15/2022	Employee stock option plan	From the Issuer			5934	08/26/2025	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Aharon Mullokandov Gilat House, 21 Yegia Kapayim Street Kiryat Arye Petah Tikva L3 4913020	Ordinary	08/20/2025	8760	79278.00
Aharon Mullokandov Gilat House, 21 Yegia Kapayim Street, Ki Petah Tikva L3 4913020	Ordinary	08/21/2025	7160	66302.57

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares is the GILT filer proposing to sell?

The filer proposes to sell 5,934 ordinary shares on or about 08/26/2025 via Oppenheimer & Co. on Nasdaq.

How and when were the shares acquired?

The shares were acquired on 05/15/2022 under an employee stock option plan and payment is listed as cash upon exercise.

Did the filer sell any shares recently?

Yes. The filer sold 8,760 shares on 08/20/2025 for $79,278.00 and 7,160 shares on 08/21/2025 for $66,302.57.

What is the number of outstanding shares reported?

The filing reports 57,017,032 shares outstanding.

What does the filer represent about material nonpublic information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.